No Data
No Data
Jim Cramer on Catalyst Pharmaceuticals (CPRX): 'That's My Kind of Stock!'
With 81% Ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), Institutional Investors Have a Lot Riding on the Business
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Investors Are Less Pessimistic Than Expected